Stockscreener 앱 받기
19.50
0.36%
-0.07
시장 영업 전:
19.00
-0.50
-2.56%
전일 마감가:
$19.57
열려 있는:
$19.57
하루 거래량:
632.10K
Relative Volume:
0.74
시가총액:
$1.22B
수익:
$330.50M
순이익/손실:
$145.42M
주가수익비율:
11.82
EPS:
1.65
순현금흐름:
$157.96M
1주 성능:
-0.41%
1개월 성능:
-7.14%
6개월 성능:
+4.00%
1년 성능:
+13.44%
1일 변동 폭
$19.41
$19.69
1주일 범위
$19.35
$20.58
52주 변동 폭
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
명칭
Innoviva Inc
전화
(650) 238-9600
주소
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
INVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
19.50 | 1.23B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 개시 | Goldman | Neutral |
| 2017-11-20 | 개시 | Deutsche Bank | Hold |
모두보기
Innoviva Inc 주식(INVA)의 최신 뉴스
What drives Innoviva Inc. stock priceRapid capital growth - jammulinksnews.com
Innoviva Inc. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia
Teacher Retirement System of Texas Reduces Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Financial Analysis: Innoviva (NASDAQ:INVA) versus Bayer Aktiengesellschaft (OTCMKTS:BAYRY) - Defense World
Is Innoviva Inc. a good long term investmentSuperior stock growth - Autocar Professional
What analysts say about Innoviva Inc. stockFree Market Dynamics Reports - jammulinksnews.com
What risks could impact Innoviva Inc. stock performanceSafe Entry High Exit Alerts - Newser
Innoviva (NASDAQ:INVA) & Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Financial Review - Defense World
Equities Analysts Set Expectations for Innoviva Q2 Earnings - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Acquired by Principal Financial Group Inc. - Defense World
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Coverage Initiated at HC Wainwright - Defense World
What makes Innoviva Inc. stock price move sharplyTop Gaining Low Risk Assets - Newser
How Innoviva Inc. stock performs during market volatilityFree Exclusive Group - Newser
Why Innoviva Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
H.C. Wainwright Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $40 - 富途牛牛
HC Wainwright Initiates Innoviva at Buy With $40 Price Target - MarketScreener
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Cantor Fitzgerald Predicts Innoviva FY2026 Earnings - Defense World
Cantor Fitzgerald Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
New York State Teachers Retirement System Sells 3,448 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Head to Head Analysis: Merck & Co., Inc. (NYSE:MRK) versus Innoviva (NASDAQ:INVA) - Defense World
(INVA) Long Term Investment Analysis - news.stocktradersdaily.com
Illinois Municipal Retirement Fund Sells 1,260 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Ratio Stays Despite Growth Signs Nasdaq Composite - Kalkine Media
Innoviva, Inc.'s (NASDAQ:INVA) Low P/S No Reason For Excitement - simplywall.st
SG Americas Securities LLC Makes New $737,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Sells 9,188 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
FDA Grants Priority Review for Innoviva's (INVA) Zoliflodacin | - GuruFocus
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 - Kalkine Media
FDA reviews new gonorrhea antibiotic from Innoviva By Investing.com - Investing.com South Africa
FDA Reviews Innoviva's (INVA) Zoliflodacin for Gonorrhea Treatment - GuruFocus
Innoviva Says FDA Accepts New Drug Application for Zoliflodacin - MarketScreener
Innoviva Specialty's gonorrhea antibiotic to undergo FDA review (INVA) - Seeking Alpha
FDA reviews new gonorrhea antibiotic from Innoviva - Investing.com Australia
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults - BioSpace
Innoviva (INVA) Awaits FDA Decision on New Gonorrhea Antibiotic | INVA Stock News - GuruFocus
Transcript : Innoviva, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Innoviva Inc (INVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Innoviva Inc 주식 (INVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
0.87%
0.17%
자본화:
|
볼륨(24시간):